TATAELXSI DAILYBullish Gartley
VERTICAL DOTTED LINE is Ultra high volume down bar
Higher volume-Professionals are buying into the public selling
Price need to follow Accelerted TREND LINE i.e green line and hit targets else if price breaks PRIMARY TREN D LINE i.e exit trade with small loss before SL
Looking to BUY with those TARGETS and SL
IIFL FINANCEIIFL Finance Ltd. (CMP ₹545.00, NSE: IIFL)
Prepared by Sucrit Patil | The SmartWay Research Desk | 10 July 2026
A Mumbai‑based diversified financial services company, incorporated in 1995. IIFL Finance operates across retail loans, gold loans, housing finance, microfinance, and wealth management, serving over 8 million customers across India.
Promoter Holding (Mar 2026): Nirmal Jain & R. Venkataraman — 24.92% stake (no pledges)
FY22–FY26 Snapshot
Revenue Growth: FY26 revenue ₹8,842 Cr vs ₹7,912 Cr in FY25 (+11.7% YoY). → Good
Net Profit: FY26 PAT ₹1,215 Cr vs ₹1,082 Cr in FY25 (+12.3% YoY). → Good
Operating Margin: FY26 EBITDA ₹2,012 Cr, margin 22.7% vs 21.9% last year (+80 bps). → Good
Equity Capital: Stable, face value ₹2. → Good
Dividend Policy: Dividend ₹10.00/share declared for FY26. → Good
Asset Building: Investments in digital lending platforms and housing finance subsidiaries. → Good
Sales: Strong demand from gold loans and retail credit. → Good
Expense: Credit cost pressures remain; GNPA ~2.1%. → Neutral/Good
EPS: FY26 EPS ₹38.25 vs ₹34.10 last year (+12.2%). → Good
Institutional Interest & Ownership Trends (Mar 2026)
Promoter Holding: 24.92% (no pledges)
FII Holding: 21.12%
DII Holding: 28.34%
Retail & Others: 25.62%
Strategic Moves & Innovations
Expansion in digital lending and fintech partnerships.
Focus on gold loans and affordable housing finance.
Partnerships with NBFCs and banks for co‑lending.
Diversification into microfinance and SME lending.
Cash Flow & Balance Sheet Strength
Market cap ~₹20,200 Cr.
Debt‑to‑equity ratio ~3.2 (high leverage typical of NBFCs).
Book value per share ₹182.40; P/B ~2.99.
EPS (TTM) ₹38.25; P/E ~14.2.
Risk Factors
Dependence on interest rate cycles and RBI regulations.
Exposure to credit risk in retail and SME segments.
Competition from Bajaj Finance, Muthoot Finance, and Manappuram Finance.
Margin pressure if credit costs rise.
Investor Takeaway
IIFL Finance has delivered steady FY26 performance, with revenue and profit growth supported by gold loans, housing finance, and digital lending. With promoter backing, dividend payouts, and diversified operations, IIFL remains a mid‑cap NBFC play. At CMP ₹545.00, valuations are reasonable (P/E ~14.2, P/B ~2.99), making it attractive for investors seeking exposure to India’s retail lending and financial services growth.
Rising Wedge Signals Possible Long-Term CorrectionMayur Uniquoters Ltd. has rallied sharply over the past several months and is now trading near the upper boundary of a long-term rising channel, a zone that has historically acted as significant resistance.
From a pure price action perspective, the current monthly structure suggests the possibility of a corrective phase after the recent vertical advance. Such moves are common after strong impulsive rallies as the market attempts to retest breakout zones and absorb profit booking before deciding on the next major trend.
Technical Observations
Price has reached the upper trendline of a multi-year ascending channel.
The recent impulsive move appears extended relative to previous swing advances.
Rejection or consolidation near long-term resistance increases the probability of a medium-term pullback.
If selling pressure strengthens, price could gradually move toward lower channel support over the coming months.
A successful hold above major support after correction would be necessary before the long-term bullish trend can resume.
The chart presents two possible paths :
Primary expectation: A healthy corrective decline toward lower support levels before the next sustainable advance.
Alternate scenario: Limited consolidation near current levels followed by continuation if buyers successfully defend the breakout zone.
About the Company
Mayur Uniquoters Limited is one of India's leading manufacturers of premium synthetic leather (PVC and PU coated fabrics). The company supplies high-performance artificial leather for multiple industries and has established relationships with leading domestic and international OEMs.
Key Products
Automotive upholstery
Artificial leather for passenger vehicles and commercial vehicles
Footwear materials
Furnishing and upholstery fabrics
Fashion accessories
Sports goods
Automotive interiors
Technical coated fabrics
Disclaimer:
This analysis is based only on the monthly chart pattern and technical price structure. It does not consider the company's financial performance, valuations, news flow, macroeconomic factors, or corporate developments. The illustrated paths represent potential technical scenarios rather than predictions. Investors and traders should conduct their own research and apply appropriate risk management before making any investment decisions.
Suven Life Sciences: Long-Term Channel Breakout in FocusSuven Life Sciences Limited appears to be trading within a well-defined long-term ascending channel on the weekly logarithmic chart. After a prolonged consolidation phase, price has once again approached a major resistance zone near the upper range of its recent structure, making this an important level to monitor over the coming months.
From a pure chart perspective, a sustained breakout above the current resistance could confirm the continuation of the long-term primary uptrend. If bullish momentum strengthens and the stock manages to hold above the breakout zone, the broader ascending channel indicates the potential for a significant upside expansion over the longer term. Until then, the current region remains a decisive technical inflection point where either continuation or rejection could unfold.
The bullish outlook presented here is based solely on the price structure, trend channel, and long-term technical pattern, without considering earnings, valuations, news flow, or macroeconomic factors.
About the Company
Suven Life Sciences Limited is an Indian biopharmaceutical research company focused on discovering and developing novel drug candidates for disorders affecting the central nervous system (CNS). The company is engaged in innovative drug research targeting diseases such as Alzheimer's, Parkinson's, depression, and other neurological conditions through proprietary molecules and research programs.
Technical View
Weekly logarithmic timeframe.
Long-term ascending channel remains intact.
Price is testing a significant resistance area.
A confirmed breakout could initiate the next leg of the primary uptrend.
Failure to sustain above resistance may result in a corrective move toward the channel support before the broader trend resumes.
Disclaimer
This publication reflects only a technical chart-based opinion and is intended for educational purposes. It does not constitute investment advice or a recommendation to buy or sell any security. Always perform your own research, evaluate company fundamentals, monitor risk carefully, and consult a qualified financial advisor before making investment decisions.
TCS | The Downtrend Holds — Selling Into The Flip Zone!By analyzing the #TCS (Tata Consultancy Services) chart on the Daily timeframe, we can see that price remains locked in a clear, well-established downtrend.
The shift began when price broke below ₹3,585 on February 28, 2025 — and from that moment on, the structure flipped decisively. What used to be a rhythm of bullish BOS after bullish BOS turned into a steady sequence of bearish BOS, one after another.
📊 Daily Timeframe
After that first bearish BOS, price managed one corrective rally — climbing back up into the Fair Value Gap (FVG) sitting between ₹3,258.10 – ₹3,397.65 , right beneath the Protected High.
That rally was rejected hard, and the resulting sell-off produced yet another BOS. Since then, price has simply been unable to reclaim any meaningful ground — every attempt higher has been met with sellers, and the stair-step lower has continued uninterrupted.
Price is currently trading around ₹2,049.50 , sitting below the Flip Zone at ₹2,357.45 – ₹2,617.50 . This zone is the key area of interest. Inside it rests buy-side liquidity (BSL) at ₹2,452.60 — a pool of resting orders that price would likely want to sweep before continuing lower.
🎯 The Bias
My expectation is straightforward: if price rallies up into the Flip Zone, it sweeps the buy-side liquidity at ₹2,452.60 inside the zone, gets rejected, and then rolls over directly toward the sell-side liquidity (SSL) resting far below at ₹1,520.20 .
In my view, the path of least resistance remains lower. The Flip Zone is a supply area, not a demand area — and until price can reclaim the Protected High region and break the bearish sequence of BOS, every rally into that zone is a selling opportunity rather than a reversal signal. The structural invalidation sits above the Protected High.
📰 Fundamental Backdrop
The timing here is significant: TCS reported its Q1 FY27 results today, July 9, officially kicking off India's earnings season. The headline numbers looked reasonable on the surface — net profit rose about 5% YoY to ₹13,349 crore and revenue climbed 13.9% YoY to ₹72,275 crore, beating estimates on the back of higher banking-client tech spending and a weaker rupee. The company also declared a ₹12 interim dividend and announced a landmark US$800 million AI-led transformation deal with SKF, while annualized AI revenue reached US$2.6 billion, up 13.6% QoQ. But look beneath the surface and the picture is softer: constant-currency growth was just 0.4% QoQ, operating margin sits at 24.0% under pressure from wage revisions, and the company booked a ₹668 crore exceptional legal claim cost. Add heightened geopolitical risk from the US-Israel-Iran conflict, continued pressure on discretionary IT spending, and AI-led repricing of traditional software and consulting models — and the fundamental backdrop aligns neatly with the bearish technical structure. The stock dipped over 2% intraday to ₹2,016 before recovering to close near flat, and management's forward commentary will be the next real test.
This analysis will be updated as the market evolves. If this breakdown added value, drop a like 👍 and a comment 💬 to support the work — and share where you see TCS heading next! Best Regards, BigBeluga 🐳
Review and plan for 10th July 2026Nifty future and banknifty future analysis and intraday plan.
This video is for information/education purpose only. you are 100% responsible for any actions you take by reading/viewing this post.
please consult your financial advisor before taking any action.
----Vinaykumar hiremath, CMT






















